We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vitamin D Is a Prognostic Marker in Heart Failure

By HospiMedica International staff writers
Posted on 13 Sep 2010
Survival rates in heart failure patients with reduced levels of vitamin D are lower than in patients with normal levels, according to a new study.

Researchers at University Medical Center (Groningen, The Netherlands) assessed vitamin D concentration in plasma samples from 548 heart failure patients; the patients were divided into three groups depending on their blood levels of vitamin D. More...
Over the 18 months of follow-up, 165 patients died and 142 were hospitalized again. The researchers found that those patients with the lowest vitamin D levels were 30% more likely to be hospitalized again or die than people with the highest levels. The effect of vitamin D levels held even after accounting for other factors. The researchers also found significant correlations between vitamin D, plasma Renin activity, and C-Reactive Protein (CRP) levels.

According to the researchers, there are several potential reasons for low vitamin D levels in heart failure patients. It might due to the fact that they are often bedridden or house-bound due to their clinical symptoms, leading to a serious deficiency in sunlight. Another factor is that the capacity of the skin to produce vitamin D declines with age, and as heart failure has a high incidence among elderly people, it is not entirely surprising to measure low levels. Severe heart failure is also associated with impaired renal function due to decreased blood supply; this may be responsible for a reduced synthesis of the active form of vitamin D, since the final step of conversion takes place in the kidneys.

Vitamin D has also been suggested as a negative regulator of the Renin Angiotensin System (RAS), which is responsible for volume and blood pressure homeostasis and is a pivotal regulatory system in heart failure. Low levels may activate the RAS, which in turn may contribute to the development and progression of heart failure. Several studies have shown that vitamin D also alters the cytokine profile and may therefore contribute to the inflammatory processes in heart failure. The study was presented at the European Society of Cardiology (ECS) annual congress, held during August-September 2010, in Stockholm (Sweden).

"By showing that vitamin D is an independent predictor, we hoped to prove that it is a contributory factor to, rather than peripheral to, the development and prognosis of heart failure,” said lead author and study presenter Licette Liu, B.Sc. "With this new information, we then hope to provide better insight into the pathophysiology of heart failure.”

Vitamin D is produced by the skin when it is exposed to the natural Ultra Violet-B (UV-B) radiation from the sun. Low levels have long been known as the underlying mechanism of rickets. Recent studies, however, have provided novel insight into the vitamin's other functions. It has been shown that most tissues and cells have a vitamin D receptor, and there is strong evidence that it's presence plays a part in reducing the risk factor profiles of several chronic illnesses, such as common cancers, autoimmune diseases, kidney diseases, chronic infectious diseases, hypertension, and now, apparently heart failure as well.

Related Links:

University Medical Center




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.